As part of our ongoing effort to interrogate SHP2 biology and to better define the antitumor activities elicited by SHP2-AIs, we compared several relatively well-studied SHP2-AIs in both cellular and mouse cancer models. The gene discussed is PTPN11; the disease is cancer.